| 1 | 7675408 | DNA-based prenatal determination of the RhEe genotype. | Obstet Gynecol | 1995 Oct |
1 |
| 2 | 7833484 | Rh E/e genotyping by allele-specific primer amplification. | Blood | 1995 Feb 1 |
9 |
| 3 | 8504984 | The use of recombinant human erythropoietin to prevent carboplatin-induced anemia. | Gynecol Oncol | 1993 May |
3 |
| 4 | 8969812 | Effect of chronic erythropoietin administration on plasma iron in newborn lambs. | Biol Neonate | 1996 |
11 |
| 5 | 12660384 | A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. | N Engl J Med | 2003 Mar 27 |
4 |
| 6 | 12842979 | CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy. | Blood | 2003 Nov 1 |
3 |
| 7 | 14676627 | The FIP1L1-PDGFRalpha kinase in hypereosinophilic syndrome and chronic eosinophilic leukemia. | Curr Opin Hematol | 2004 Jan |
5 |
| 8 | 14676628 | Clinical, genetic, and therapeutic insights into systemic mast cell disease. | Curr Opin Hematol | 2004 Jan |
1 |
| 9 | 14749727 | Human Fip1 is a subunit of CPSF that binds to U-rich RNA elements and stimulates poly(A) polymerase. | EMBO J | 2004 Feb 11 |
2 |
| 10 | 14757533 | Targeted treatment of hypereosinophilic syndromes and chronic eosinophilic leukemias with imatinib mesylate. | Semin Cancer Biol | 2004 Feb |
2 |
| 11 | 14973504 | Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias. | Leukemia | 2004 Apr |
3 |
| 12 | 15003901 | Imatinib mesylate can induce complete molecular remission in FIP1L1-PDGFR-a positive idiopathic hypereosinophilic syndrome. | Haematologica | 2004 Feb |
1 |
| 13 | 15036941 | Imatinib therapy for hypereosinophilic syndrome and eosinophilia-associated myeloproliferative disorders. | Leuk Res | 2004 May |
1 |
| 14 | 15175999 | Platelet-derived growth factor receptor inhibition to treat idiopathic hypereosinophilic syndrome. | Semin Oncol | 2004 Apr |
6 |
| 15 | 15284118 | FIP1L1-PDGFRA fusion: prevalence and clinicopathologic correlates in 89 consecutive patients with moderate to severe eosinophilia. | Blood | 2004 Nov 15 |
1 |
| 16 | 15305431 | Targeted treatment of hypereosinophilic syndromes and chronic eosinophilic leukemias with imatinib mesylate. | Semin Cancer Biol | 2004 Aug |
2 |
| 17 | 15339694 | Soft tissue and skeletal involvement in FIP1L1-PDGFR-alpha positive chronic eosinophilic leukemia: imatinib mesylate may induce complete molecular and imaging remission. | Haematologica | 2004 Aug |
1 |
| 18 | 15455302 | [Complete remission of an idiopathic hypereosinophilic syndrome while using imatinib]. | Dtsch Med Wochenschr | 2004 Oct 1 |
1 |
| 19 | 15500716 | [Identification of FIP1L1-PDGFRA fusion, and expression of signal transducer and activator of transcription 5 in hypereosinophilic syndrome]. | Zhonghua Yi Xue Za Zhi | 2004 Sep 17 |
1 |
| 20 | 15567248 | Effects of the plant alkaloid thaliblastine on non-cross-resistant and sensitive human leukemia cells in relation with reversal of acquired anthracycline resistance. | Fitoterapia | 2004 Dec |
1 |
| 21 | 15618966 | Myeloid blast crisis evolving during imatinib treatment of an FIP1L1-PDGFR alpha-positive chronic myeloproliferative disease with prominent eosinophilia. | Leukemia | 2005 Feb |
1 |
| 22 | 15621768 | Rapid reversion of Loeffler's endocarditis by imatinib in early stage clonal hypereosinophilic syndrome. | Leuk Lymphoma | 2004 Dec |
1 |
| 23 | 15700042 | Early endostatin treatment inhibits metastatic seeding of murine colorectal cancer cells in the liver and their adhesion to endothelial cells. | Br J Cancer | 2005 Feb 28 |
1 |
| 24 | 15854548 | [The activation of JAK/STAT signal pathway in hypereosinophilic syndrome and the patients therapeutic response to imatinib]. | Zhonghua Yi Xue Za Zhi | 2005 Feb 23 |
3 |
| 25 | 15921304 | [Disorders with eosinophilia, treatment of hypereosinophilic syndrome]. | Orv Hetil | 2005 May 1 |
1 |
| 26 | 15937220 | Analysis of a noncanonical poly(A) site reveals a tripartite mechanism for vertebrate poly(A) site recognition. | Genes Dev | 2005 Jun 1 |
1 |
| 27 | 15995324 | Systemic mastocytosis: bone marrow pathology, classification, and current therapies. | Acta Haematol | 2005 |
1 |
| 28 | 16030188 | The small molecule tyrosine kinase inhibitor AMN107 inhibits TEL-PDGFRbeta and FIP1L1-PDGFRalpha in vitro and in vivo. | Blood | 2005 Nov 1 |
1 |
| 29 | 16089297 | FIP1L1-PDGFR alpha, a therapeutic target for the treatment of chronic eosinophilic leukemia. | Verh K Acad Geneeskd Belg | 2005 |
3 |
| 30 | 16344672 | Idiopathic hypereosinophilic syndrome in children: report of a 7-year-old boy with FIP1L1-PDGFRA rearrangement. | J Pediatr Hematol Oncol | 2005 Dec |
1 |
| 31 | 16406016 | FIP1L1-PDGFRA in eosinophilic disorders: prevalence in routine clinical practice, long-term experience with imatinib therapy, and a critical review of the literature. | Leuk Res | 2006 Aug |
2 |
| 32 | 16406018 | Systemic mastocytosis (SM) associated with chronic eosinophilic leukemia (SM-CEL): detection of FIP1L1/PDGFRalpha, classification by WHO criteria, and response to therapy with imatinib. | Leuk Res | 2006 Sep |
1 |
| 33 | 16479834 | [Oncogene Fip1-likeL/PDGFRalpha as a target for imatinib in patients with hypereosinophilic syndrome and chronic eosinophilic leukemia. A novel look at pathogenesis and therapy]. | Pol Arch Med Wewn | 2005 May |
1 |
| 34 | 16485879 | A comprehensive review of imatinib mesylate (Gleevec) for dermatological diseases. | J Drugs Dermatol | 2006 Feb |
1 |
| 35 | 16612767 | Hypereosinophilic syndrome: lymphoproliferative and myeloproliferative variants. | Semin Respir Crit Care Med | 2006 Apr |
1 |
| 36 | 16645167 | Sorafenib is a potent inhibitor of FIP1L1-PDGFRalpha and the imatinib-resistant FIP1L1-PDGFRalpha T674I mutant. | Blood | 2006 Aug 15 |
7 |
| 37 | 16682077 | Activity of AMN107, a novel aminopyrimidine tyrosine kinase inhibitor, against human FIP1L1-PDGFR-alpha-expressing cells. | Leuk Res | 2006 Dec |
2 |
| 38 | 16690743 | Activation of FIP1L1-PDGFRalpha requires disruption of the juxtamembrane domain of PDGFRalpha and is FIP1L1-independent. | Proc Natl Acad Sci U S A | 2006 May 23 |
1 |
| 39 | 16754777 | The FIP1L1-PDGFRA T674I mutation can be inhibited by the tyrosine kinase inhibitor AMN107 (nilotinib). | Blood | 2006 Jun 15 |
2 |
| 40 | 16781490 | Pathogenesis, clinical features, and treatment advances in mastocytosis. | Best Pract Res Clin Haematol | 2006 |
1 |
| 41 | 16965435 | Platelet-derived growth factor receptor-alpha-associated hypereosinophilic syndrome and lymphomatoid papulosis. | Br J Dermatol | 2006 Oct |
1 |
| 42 | 17215855 | FIP1L1-PDGFRA in chronic eosinophilic leukemia and BCR-ABL1 in chronic myeloid leukemia affect different leukemic cells. | Leukemia | 2007 Mar |
1 |
| 43 | 17258775 | Differentiation of eosinophilic leukemia EoL-1 cells into eosinophils induced by histone deacetylase inhibitors. | Life Sci | 2007 Mar 6 |
1 |
| 44 | 17299092 | Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia. | Blood | 2007 Jun 1 |
5 |
| 45 | 17440089 | Molecular mechanisms underlying FIP1L1-PDGFRA-mediated myeloproliferation. | Cancer Res | 2007 Apr 15 |
2 |
| 46 | 17488167 | Systemic mastocytosis: a concise clinical and laboratory review. | Arch Pathol Lab Med | 2007 May |
1 |
| 47 | 17495975 | The novel tyrosine kinase inhibitor EXEL-0862 induces apoptosis in human FIP1L1-PDGFR-alpha-expressing cells through caspase-3-mediated cleavage of Mcl-1. | Leukemia | 2007 Jul |
3 |
| 48 | 17541270 | Recent advances in eosinophil biology. | Int Arch Allergy Immunol | 2007 |
1 |
| 49 | 17541273 | Mechanism for the differentiation of EoL-1 cells into eosinophils by histone deacetylase inhibitors. | Int Arch Allergy Immunol | 2007 |
4 |
| 50 | 17544504 | Maintenance therapy with imatinib appears necessary despite molecular remission in FIP1L1-PDGFRA fusion gene positive hypereosinophilic disorder. | Leuk Res | 2008 Jan |
2 |